Intranasal Cooling for Symptomatic Relief of Migraine

NATerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Migraine Headache
Interventions
DEVICE

Active RhinoChill

"The device is intended for use for the reduction of temperature via the nasal cavity.~The RhinoChill® System is a British Standards Institution Kite-Marked device that is currently commercially available in Europe. The RhinoChill® device is intended for temperature reduction in patients via the nasal cavity."

DEVICE

Placebo RhinoChill

The placebo RhinoChill device looks and functions in an identical way to the active RhinoChill. All components are used, however through some minor changes in the design of the device it now provides a sufficient placebo treatment to the patient.

Trial Locations (3)

CA11 8HX

Neurosciences department, Penrith Hospital, Cumbria Partnership NHS Foundation Trust, Penrith

SR4 7TP

CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST, 11 Norfolk Street, Sunderland SR1 1EA, Sunderland

TS4 3BW

The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BeneChill, Inc

INDUSTRY

lead

Cumbria Partnership NHS Foundation Trust

OTHER